C.M. Bidwell & Associates »

BioCryst Pharmaceuticals shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.7k 361 7.59
2025-06-30 $69k 7.8k 8.96
2021-09-30 $201k 14k 14.35
2021-06-30 $221k 14k 15.78

More positions owned by C.M. Bidwell & Associates

Vanguard S&p 500 Etf idx (VOO)
Vanguard Short-Term Bond ETF (BSV)
Vanguard Total Stock Market ETF (VTI)
iShares Russell 2000 Index (IWM)
Vanguard Malvern Fds strm infproidx (VTIP)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
iShares S&P 500 Index (IVV)
Schwab Strategic Tr sht tm us tres (SCHO)
Ishares Tr core strm usbd (ISTB)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Europe Pacific ETF (VEA)
Vanguard Total Bond Market ETF (BND)
Dimensional Etf Trust (DFAC)
Schwab Strategic Tr 0 (SCHP)
Schwab U S Broad Market ETF (SCHB)

View all positions for C.M. Bidwell & Associates

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals